Over 80% of the 400,000 children who develop cancer each year live in low-income and middle-income countries. Due to a complex range of poverty related limitations, markedly different levels of access to quality care and rates of treatment abandonment are seen). As a result, more than 75% of these children will die of their disease. Most of these deaths are preventable.
TLM has created 2 powerful medical devices to modify these entirely unacceptable LMICs Childhood cancer outcomes dramatically, with the potential of saving countless young lives. Our programme ‘CleverCancerCare’ Applications consisting of 2 synergistic web-based applications: CleverCharts and CleverChemo:CleverCancerCare is unique and has the potential to help save the lives of 100,000s of children diagnosed with cancer in LMICs worldwide. It will ensure strict adherence to treatment protocols and minimize human errors in chemotherapy scheduling, calculations, and other protocol directed decisions.
